1. Araki H, Fujiwara H, Tanaka C (1981) Age-related changes in the chronotropic effect and the enzymic decarboxylation of L-threo-3,4-dihydroxyphenylserine in the rat heart. J Pharm Pharmacol 33: 778–782
2. Barbeau A (1974) The clinical physiology of side effects in long-term L-DOPA therapy. In: McDowell F H, Barbeau A (eds) Advances in neurology 5. Raven Press, New York, pp 347–365
3. Bartholini G, Constantidinis J, Puig M, Tissot R, Pletscher A (1975) The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine. J Pharmacol Exp Ther 193: 523–532
4. Bartholini G, Constantinidis J, Tissot R, Pletscher A (1971) Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase. Biochem Pharmacol 20: 1243–1247
5. Bernheimer H, Birkmayer W, Hornykiewicz O (1963) Zur Biochemie des Parkinson — Syndroms des Menschen—Einfluß der Monoaminoxydase-Hemmer-Therapie auf die Konzentration des Dopamins, Noradrenalins und 5-Hydroxytryptamins im Gehirn. Klin Wschr 41: 465–469